Cerus Corp. (CERS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1220 CONCORD AVENUE CONCORD, CA 94520

Cerus Corp. develops medical systems and therapeutics based on its proprietary Helinx technology for controlling biological replication. The company's programs are focused on systems to enhance the safety of blood products used for transfusion, using its Listeria vaccine platform.

Data as of 2021-02-27 10:00:26 -0500
Market Cap1.033 Billion Shares Outstanding168.22 Million Avg 30-day Volume2.013 Million
P/E Ratio-16.55269 Dividend Yield EPS-0.395
Price/Sales9.95 Debt to Equity1.95 EBITDA-57.5 Million
Price to Book Value9.46 Forward PE Enterprise Value942.274 Million
Total Cash135.124 Million Current Debt46.189 Million Gross Profit65.492 Million
BETA1.1386 52-week High/Low8.87 / 2.71 Next Earnings Date2021-02-25 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CERS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 2 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 162 161 0.62% 48 (2.9%) 48 (2.99%) 0.0%
13F shares: 140.825 Million 137.15 Million 2.68% 70.599 Million 70.353 Million 0.35%
% Ownership 84.2546 82.0562 2.68% 42.239 42.0916 0.35%
New Positions: 24 24 0.0% 10 10 0.0%
Increased Positions 53 52 1.92% 13 13 0.0%
Closed Positions 20 20 0.0% 10 8 25.0%
Reduced Positions 50 51 -1.96% 17 17 0.0%
Total Calls 513.328 Thousand 487.616 Thousand 5.27% 56.2 Thousand 76.4 Thousand -26.44%
Total Puts 173.529 Thousand 371.97 Thousand -53.35% 28.2 Thousand 42.4 Thousand -33.49%
PUT/CALL Ratio 0.34 0.76 -55.26% 0.5 0.55 -9.09%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Cerus Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding CERS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CERS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

18.1 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

18.1 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CORASH LAURENCE M CHIEF SCIENTIFIC OFFICER

  • Officer
 150,000 2021-03-01 3

GREENMAN WILLIAM MARINER PRESIDENT AND CEO

  • Officer
  • Director
 574,000 2021-03-01 3

GREEN KEVIN DENNIS CHIEF FINANCIAL OFFICER

  • Officer
 195,000 2021-03-01 4

MENARD CHRYSTAL CHIEF LEGAL OFFICER

  • Officer
 150,000 2021-03-01 7

MOORE CAROL SVP REG. & QUALITY

  • Officer
 105,000 2021-03-01 5

BENJAMIN RICHARD J CHIEF MEDICAL OFFICER

  • Officer
 150,000 2021-03-01 4

JAYARAMAN VIVEK K CHIEF OPERATING OFFICER

  • Officer
 225,000 2021-03-01 5

SWISHER DANIEL N JR

  • Director
 59,868 2021-02-16 4

ANDERSON TIMOTHY B

  • Director
 200,765 2020-12-22 5

SCHULZE GAIL

  • Director
 0 2020-12-14 3

BJERKHOLT ERIC

  • Director
 28,563 2020-10-05 2

MOORE TIMOTHY L.

  • Director
 12,207 2020-09-05 2

WITNEY FRANK

  • Director
 71,489 2020-06-05 2

NACHTSHEIM JAMI K

  • Director
 0 2020-06-03 1

COZADD BRUCE C

  • Director
 18,921 2017-06-06 0

HOGEBOOM CASPAR JAN PRESIDENT, CERUS EUROPE

  • Officer
 0 2015-12-10 0

CASSIN BJ

  • Director
 332,225 2013-11-04 0

ERVIN HOWARD G VICE PRESIDENT, LEGAL AFFAIRS

  • Officer
 42,846 2013-01-07 0

GLASSELL CLAES EXECUTIVE OFFICER AND DIRECTOR

  • Officer
  • Director
 0 2011-04-01 0

ROHN WILLIAM R

  • Director
 0 2011-01-03 0

DAWSON WILLIAM J CHIEF FINANCIAL OFFICER

  • Officer
 0 2009-01-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MOORE CAROL - Officer SVP REG. & QUALITY

2021-03-03 20:13:07 -0500 2021-03-01 A 35,000 a 35,000 direct

JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

2021-03-03 20:11:05 -0500 2021-03-01 A 150,000 a 150,000 direct

GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

2021-03-03 20:04:06 -0500 2021-03-01 A 65,000 a 65,000 direct

CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

2021-03-03 20:02:09 -0500 2021-03-01 A 100,000 a 100,000 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-03-03 20:15:55 -0500 2021-03-01 A 50,000 a 50,000 direct

MOORE CAROL - Officer SVP REG. & QUALITY

2021-03-03 20:13:07 -0500 2021-03-01 A 70,000 a 70,000 direct

GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

2021-03-03 20:08:30 -0500 2021-03-01 A 194,000 a 194,000 direct

GREEN KEVIN DENNIS - Officer CHIEF FINANCIAL OFFICER

2021-03-03 20:04:06 -0500 2021-03-01 A 130,000 a 130,000 direct

BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

2021-03-03 19:59:39 -0500 2021-03-01 A 50,000 a 50,000 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-03-03 20:15:55 -0500 2021-03-01 A 100,000 a 100,000 direct

JAYARAMAN VIVEK K - Officer CHIEF OPERATING OFFICER

2021-03-03 20:11:05 -0500 2021-03-01 A 75,000 a 75,000 direct

GREENMAN WILLIAM MARINER - Director - Officer PRESIDENT AND CEO

2021-03-03 20:08:30 -0500 2021-03-01 A 380,000 a 380,000 direct

CORASH LAURENCE M - Officer CHIEF SCIENTIFIC OFFICER

2021-03-03 20:02:09 -0500 2021-03-01 A 50,000 a 50,000 direct

BENJAMIN RICHARD J - Officer CHIEF MEDICAL OFFICER

2021-03-03 19:59:39 -0500 2021-03-01 A 100,000 a 100,000 direct

SWISHER DANIEL N JR - Director

2021-02-18 18:46:41 -0500 2021-02-16 M 10,000 d 5,000 direct

SWISHER DANIEL N JR - Director

2021-02-18 18:46:41 -0500 2021-02-16 S 10,000 $7.78 d 59,868 direct

SWISHER DANIEL N JR - Director

2021-02-18 18:46:41 -0500 2021-02-16 M 10,000 $2.90 a 69,868 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-02-11 17:59:26 -0500 2021-02-08 M 4,167 $4.33 a 52,752 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-02-11 17:59:26 -0500 2021-02-08 M 3,958 d 29,688 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-02-11 17:59:26 -0500 2021-02-08 M 3,958 $4.32 a 52,543 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-02-11 17:59:26 -0500 2021-02-08 M 4,167 d 6,250 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-02-11 17:59:26 -0500 2021-02-08 S 4,167 $8.00 d 48,585 direct

MENARD CHRYSTAL - Officer CHIEF LEGAL OFFICER

2021-02-11 17:59:26 -0500 2021-02-08 S 3,958 $8.00 d 48,585 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CERUS CORP CERS 2021-03-05 22:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 21:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 21:15:02 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 20:45:02 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 20:15:05 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 19:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 19:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 18:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 18:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 17:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 17:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 16:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 16:15:02 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 15:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 15:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 14:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 14:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 13:45:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 13:15:03 UTC -0.18 0.25 2500000
CERUS CORP CERS 2021-03-05 12:45:03 UTC -0.18 0.25 1800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio CERS -18800.0 shares, $-130096.0 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CERS -21.0 shares, $-97.65 2020-03-31 N-PORT

Elevate your investments